  See all
 |
Articles: Basic Science |
Prior Articles
The inhibitor of protein arginine methyltransferases, ami-1 is a potent scavenger of nox-derived superoxide
Molecular Pharmacology, 11/20/09
novel roscovitine derivative potently induces G1-phase arrest in PDGF-BB-activated vascular smooth muscle cells
Molecular Pharmacology, 11/20/09 Effective vaginal DNA delivery with high transfection efficiency is a good system for induction of higher local vaginal immune responses
Journal of Pharmacy and Pharmacology, 11/18/09 Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite
British Journal of Clinical Pharmacology, 11/16/09 Multicenter Analysis of the SLC6A3/DAT1 VNTR Haplotype in Persistent ADHD Suggests Differential Involvement of the Gene in Childhood and Persistent ADHD
Neuropsychopharmacology, 11/16/09 Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity
Pharmacology & Therapeutics, 11/16/09 Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses
Clinical and Experimental Pharmacology and Physiology, 11/13/09 Structure and function of heterotrimeric g protein-regulated rho guanine nucleotide exchange factors
Molecular Pharmacology, 11/13/09 G Protein Mediated Inhibition of Cav3.2 T-type Channels Revisited
Molecular Pharmacology, 11/13/09 Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite
Drug Metabolism and Disposition, 11/12/09 If the KI is defined by the free energy of binding to P-gp, what kinetic parameters define the IC50 for the MDCKII-hMDR1 confluent cell monolayer
Drug Metabolism and Disposition, 11/12/09 Human Cytochrome P450 Oxidoreductase Deficiency Caused by the Y181D Mutation: Molecular Consequences & Rescue of Defect
Drug Metabolism and Disposition, 11/12/09 Putative Transmembrane Domain 12 of the Human Organic Anion Transporter hOAT1 Determines Transporter Stability and Maturation Efficiency
Journal of Pharmacology and Experimental Therapeutics, 11/12/09 Quantitative prediction and clinical observation of a cyp3a inhibitor-based drug-drug interactions with mln3897, a potent ccr1 antagonist
Journal of Pharmacology and Experimental Therapeutics, 11/12/09 Selective Antagonism of Opioid-Induced Ventilatory Depression by an Ampakine Molecule in Humans Without Loss of Opioid Analgesia
Clinical Pharmacology & Therapeutics, 11/12/09 Analgesic omega-conotoxins cvie and cvif selectively and voltage dependently block recombinant and native n-type calcium channels
Molecular Pharmacology, 11/11/09 Quercetin and naringenin transport across human intestinal Caco-2 cells
Journal of Pharmacy and Pharmacology, 11/10/09 An epilepsy-related region in the GABAA receptor mediates long-distance effects on GABA and benzodiazepine binding sites
Molecular Pharmacology, 11/10/09 Identification and Characterization of a Small Molecule Antagonist of Human VPAC2 Receptor
Molecular Pharmacology, 11/10/09 CCR2 receptor ligands inhibit Cav3.2 T-type calcium channels
Molecular Pharmacology, 11/10/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
